Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism
1 other identifier
interventional
76
1 country
1
Brief Summary
The goal of this study is to address surgical health equity in historically marginalized participants with primary hyperparathyroidism (PHPT). The main questions that this study aims to answer are, how does patient navigation impact:
- The proportion of PHPT participants undergo parathyroidectomy?
- The proportion of PHPT participants who complete surgical consultation?
- Time to surgical consultation?
- Time to surgery?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 20, 2024
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
March 19, 2026
March 1, 2026
8 months
August 12, 2024
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Parathyroidectomy Surgical Outcome
The primary outcome will be the proportion of patients who undergo parathyroidectomy
Within 12 months
Secondary Outcomes (8)
Completion of Consultation
Through study completion, an average of 1 year after time of recruitment or surgery
Time to Consultation
Through study completion, an average of 1 year after time of recruitment or surgery
Time to Surgery
Through study completion, an average of 1 year after time of recruitment or surgery
Complications related to hyperparathyroidism
Assessed at 6 and 12 months after recruitment or surgery in all groups
Parathyroidectomy complications
Assessed at 6 and 12 months after recruitment or surgery in all groups
- +3 more secondary outcomes
Study Arms (2)
Scheduling Navigation
EXPERIMENTALParticipants will be assigned to a scheduler.
Without Scheduling Navigation
ACTIVE COMPARATORParticipants will not be assigned to a scheduler.
Interventions
Patients will work with clinic staff in the usual fashion for their treatment for primary hyperparathyroidism. They will not be connected directly to a scheduler to help schedule a surgical consultation visit at time of recruitment. With our crossover design, if patients have not yet received surgical consultation after 3 months, they will be called and connected with a scheduler at that time. Participation does not guarantee or require surgery.
Participants will be connected to a scheduler to schedule a surgical consultation visit at time of recruitment. Participation does not guarantee or require surgery.
Eligibility Criteria
You may qualify if:
- Diagnosed with PHPT and not yet had parathyroidectomy who meet criteria for surgical treatment of PHPT (osteoporosis, fragility fracture, or evidence of vertebral compression fracture on spine imaging, renal involvement \[renal stone, silent nephrolithiasis on renal imaging, nephrocalcinosis, hypercalciuria (24-hour urine calcium level 400 mg/dL) with increased stone risk, or impaired renal function (glomerular filtration rate 60 mL/min)\], calcium 1 mg/dL above upper limit of normal, age less than 50)
- Qualify as a member of a racial or ethnic minority group (Black, Hispanic, Asian and Pacific Islander, Native American), lower socioeconomic neighborhoods (by zipcode), socially vulnerable (social determinants of health indicating financial strain, social vulnerability index in the top quartile 75%+ by zip code), or with underinsurance (Medicaid, Medicare, dual eligible, uninsured)
You may not qualify if:
- Prior Parathyroidectomy
- End-stage Renal Disease
- Renal Transplant
- Vitamin D Deficiency
- Metastatic Disease
- Familial Hypocalciuric Hypercalcemia
- No Indication for Surgery
- Unable/Unwilling to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American College of Surgeonscollaborator
- University of Pennsylvanialead
Study Sites (1)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Kelz, MD
University of Pennsylvania
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Vice Chair
Study Record Dates
First Submitted
August 12, 2024
First Posted
August 20, 2024
Study Start
May 1, 2026
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03